COMPANY
Macro Biologics
Timeline
- Trial start Phase 1: A Study of Amicidin-β Topical Solution for Patients With Surgical or Traumatic Wound Infections source ↗
Upcoming milestones
- Feb 28, 2027 (ESTIMATED) · Phase 1 · A Study of Amicidin-β Topical Solution for Patients With Surgical or Traumatic Wound Infections · NCT07379684
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT07379684 | A Study of Amicidin-β Topical Solution for Patients With Surgical or Traumatic Wound Infections | Phase 1 | Recruiting | Sep 30, 2026 | Feb 28, 2027 (estimated) |